Ingersoll Rand Buys ILC Dover, Expanding into Life Sciences
With a deal based on an approximate 17x 2024E Adjusted EBITDA multiple, Ingersoll Rand's acquisition of ILC Dover targets expansion, complementing its PST segment through robust organic growth and margins.